ELCC 2019 | Challenges in NSCLC: acquired resistance

Laura Bonanno, MD, Veneto Institute of Oncology, Padova, Italy, explains the challenges facing patients with non-small cell lung cancer (NSCLC). Dr Bonanno explains how the use of genetic screening and immunotherapy has lead to two new challenges; understanding the mechanisms which result in resistance, and how to overcome this acquired resistance. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.